INOVIO's INO-3107 Biologics License Application accepted by US FDA

ABL Bio receives upfront payment and equity investment from Eli Lilly

CARsgen Therapeutics submits two IND applications for CT0596 to Chinese regulator

Repare Therapeutics sells RP-3467 asset to Gilead Sciences for up to USD30m

Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio

Italfarmaco and JCR PHarmaceuticals strike Japan deal for givinostat and expand rare disease collaboration

Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11

Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA

NeuroSense Therapeutics completes safety evaluation of PrimeC in Alzheimer's Phase 2 study

BrioHealth Solutions enrols 100th participant in BrioVAD System trial

Neurocrine Biosciences reports Phase 3 study of valbenazine in DCP did not meet primary or key secondary endpoints

Faron launches BLAZE trial with Institute of Cancer Research to address immunotherapy resistance

AstraZeneca secures US Breakthrough status for Enhertu in early breast cancer

Ipsen licenses Simcere Zaiming antibody-drug conjugate for global development

Shield Therapeutics wins FDA approval to expand ACCRUFeR use to adolescents